Delivery Order SPE2DB22D3004-SPE2DB24FQB26

Award Date 4/19/24
Potential Completion Date 4/22/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The award, valued at $1,741.68, is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential total value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,773.64 and a period of performance ending on June 25, 2024. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen holds a larger, single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The ceiling value of the contract is $1,015.98. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical product. The contract has a ceiling value of $7,924.80 and a final completion date of June 10, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $3,773.64 firm fixed price contract has a completion date of May 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,919.12, was issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The award, valued at $53,005.00, is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The single-award Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and is the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The Firm Fixed Price Delivery Order, valued at $2,468.31, has a period of performance through June 14, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5ml. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $1,741.68 and a period of performance through June 28, 2024. This is a firm fixed-price delivery order contract, without a set-aside designation. Amerisourcebergen holds a significant Indefinite...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FQB26
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The single-award Indefinite Delivery Contract (IDC) has a ceiling value of $1,741.68 and a period of performance through April 22, 2024. This contract is part of Amerisourcebergen's larger $999,999,999.00 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation. Amerisourcebergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leverages its extensive supply chain capabilities to efficiently fulfill these types of government contracts.

Generated 7/19/24, 9:45 AM